Live Breaking News & Updates on Provides Clinically Meaningful

Data add to the growing body of evidence supporting the efficacy and safety profile of FINTEPLA for the treatment of Dravet syndrome. ....

United States , Porter Novelli , Trish Mccall , Tevard Biosciences , Bradleys Galer , Brian Ritchie , Us Securities Exchange Commission , Lifesci Advisors , American Epilepsy Society , European Commission , Drug Administration , European Early Access Program , European Medicines Agency , Annual Meeting , Better Outcomes Through Diversity , Executive Vice President , Chief Medical Officer , Zogenix Newsroom , Treatment Improves Everyday Executive Functioning , Preschool Children With Dravet Syndrome , Analysis From , Significantly Reduces Day To Seizure Burden , Increasing Seizure Free Days , Time To Event Analysis , Echocardiographic Assessment , Dravet Syndrome Treated ,